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The inner blood-retinal barrier is a gliovascular unit in which glial cells surround capil-
lary endothelial cells and regulate retinal capillaries by paracrine interactions. During 
chronic ocular inflammation, microvascular complications can give rise to vascular 
proliferative lesions, which compromise visual acuity. This pathologic remodelling 
caused by proliferating Müller cells determines occlusion of retinal capillaries. The 
aim of the present study was to identify qualitative and quantitative alterations in 
the retinal capillaries in patients with post-traumatic chronic ocular inflammation or 
post-thrombotic vascular glaucoma. Moreover, we investigated the potential role of 
vascular endothelial growth factor (VEGF) and pro-inflammatory cytokines in retinal 
inflammation. Our electron microscopy findings demonstrated that during chronic 
ocular inflammation, thickening of the basement membrane, loss of pericytes and 
endothelial cells and proliferation of Müller cells occur with irreversible occlusion 
of retinal capillaries. Angiogenesis takes place as part of a regenerative reaction 
that results in fibrosis. We believe that VEGF and pro-inflammatory cytokines may 
be potential therapeutic targets in the treatment of this disease although further 
studies are required to confirm these findings. (Folia Morphol 2015; 74, 1: 33–41)
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INTRODUCTION
The blood-retinal barrier (BRB) consists of inner 
and outer components and plays an important role 
in the homeostatic regulation of the retinal micro-
environment. The inner BRB is formed by the tight 
junctions between neighbouring capillary endothelial 
cells [47], which rest on a basal lamina covered by the 
processes of astrocytes and Müller cells [5]. Pericytes, 
separated from the endothelial cells by the basal lami-
na, together with Müller cells, contribute to the pro-
per functioning of the inner BRB [32]. The outer BRB is 
formed by tight junctions between cells of the retinal 
pigment epithelium [19], which play an important 
role in trasporting nutrients from the blood to the 
outer retina. Chronic ocular inflammation can occur 
as a consequence of age progression [16], disease, 
injury and surgery [23, 42, 50]. Inflammation is typi-
cally associated with an increase in production of pro-
-inflammatory mediators [17], such as cytokines and 
chemokines, and persistent inflammation can lead to 
impaired vision and blindness [59]. Fibroblasts play 
crucial roles in both inflammation and wound healing, 
producing pro-inflammatory mediators in response 
to injury and inflammatory stimuli [7, 49]. Epithelial 
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cells and macrophages produce a pro-inflammatory 
cytokine, interleukin-1beta (IL-1b), that increases the 
fibroblastic production of cytokines and chemokines, 
and vascular endothelial growth factor (VEGF) [11, 
43]. Monocyte chemoattractant protein (MCP)-1, IL-6 
and IL-8 produced by fibroblasts, promote immune cell 
infiltration [49]. VEGF is the most important factor in 
promoting angiogenesis, the sprouting of new capil-
laries from pre-existing blood vessels, a regulated pro-
cess essential in reproduction, development and tissue 
repair [11]. Müller cells, the glial cells of the retina, con-
stitute a functional link between neurons and vessels. 
These glial cells support neurons with blood-derived 
nutrients, remove metabolic waste and maintain the 
homeostasis of the retinal extracellular ions, water, 
neurotransmitter molecules and pH [14, 52]. Indeed, 
under inflammatory and hypoxic conditions these glial 
cells secrete factors such as VEGF, that increase the 
vascular permeability [2, 56], and matrix metallopro-
teinases [10, 36], which impair the barrier function of 
retinal endothelial cells. Under normoxic conditions, 
Müller cells secrete pigment epithelium-derived factor 
(PEDF) that decreases the barrier permeability and 
downregulates the expression of VEGF [12, 22]. VEGF 
is known to modulate immune responses by increasing 
vascular permeability. Because of its pro-inflammatory 
actions it enhances the adhesion of leucocytes to va-
scular walls and increases the levels of intercellular 
cell adhesion molecule-1 (ICAM-1) and vascular cell 
adhesion molecules-1 [31]. Up-regulation of ICAM-1 
in the vascular endothelium induces an accumulation 
of leucocytes within the retina [29, 39]. Leucocyte 
adhesion to the endothelium and migration into the 
tissues [48], mediated by ICAM-1, results in injury to 
endothelial cells followed by increased retinal vascular 
permeability, retinal oedema and loss of visual acuity 
[29]. A previous study showed that human Müller cells 
produced IL-6 after stimulation with either IL-1b or 
lipopolysaccharide and IL-6 production may have an 
important role in various conditions involving ocular 
inflammation [57]. Pro-inflammatory cytokines, such 
as IL-1b, IL-6 and tumour-necrosis factor alpha (TNFa) 
have been detected in the retinas of rats with diabetes 
[15, 40]. Under high-glucose conditions, Müller cells 
rapidly produce IL-1b [54], TNFa and IL-6. Studies using 
drugs with anti-inflammatory properties have shown 
that such treatment is able to prevent the development 
of diabetic retinopathy [33, 40].
The aim of this study was to identify by electron 
microscopy alterations which occur in the capillaries 
as a result of chronic ocular inflammation caused by 
glial cell proliferation. We investigated the expression 
of these growth factors and pro-inflammatory cyto-
kines to shed light on the etiopathogenesis of ocular 
chronic inflammation, which may have significant 
clinical consequences in terms of pharmacological 
treatment. It may play a key role in developing new 
non-surgical forms of treatment to reduce the severity 
of inflammation, angiogenesis and retinal capillary 
occlusion caused by Müller cells.
MaTeRIals aND MeThODs
Ethical considerations
Thirty enucleated human eyes (age range 38–81 
years, 18 — 6 female and 3 male patients — with 
ocular inflammatory disease and 12 — 4 female and 
2 male patients — with glaucomatous eyes), were se-
lected for these electron microscopic studies. Patients 
with inflammatory ocular disease had a moderate to 
severe grade of inflammation. Samples of retina were 
harvested from the left eye during autopsies. Since 
post-mortem phenomena may produce early morpho-
logic modifications of the eye structure, our samples 
were harvested as early as possible after death (within 
24 h). The protocol and informed written consent 
forms were approved by the Ethical Committee of 
the “Sapienza” University of Rome and G.B. Bietti 
Eye Foundation (IRCCS). Before signing the informed 
consent form, patients were informed about the study 
in detail by a physician providing them by ample time 
to ask possible questions. The study was conducted 
in accordance with the Declaration of Helsinki. 
Electron microscopy 
The ocular tissues were fixed immediately in buffer 
containing 2% glutaraldehyde for 2 h, washed and 
then postfixed in buffer 2% osmium tetroxide for 2 h, 
dehydrated and embedded in araldite. Ultrathin sec-
tions were made using a Reichert Ultra-microtome. 
These sections were counterstained by uranyl acetate 
and lead citrate and studied with Zeiss EM 109 elec-
tron microscope.
Immunohistochemical analysis
Control morphological sections were stained with 
haematoxylin–eosin (not shown). The following mole-
cules were investigated: VEGF, PEDF, IL-1b, TNFa and 
transforming growth factor beta (TGFb1).
Small fragments of retina taken from the post-
-traumatic chronic ocular inflammation or post-
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-thrombotic vascular glaucoma patients were washed 
in phosphate buffered saline (PBS), fixed in 10% 
formalin and embedded in paraffin according to 
a standard procedure. The method employed for im- 
munohistochemical tests was ABC/HRP technique 
(avidin complexed with biotinylated peroxidase). Se-
rial 3-μm thick sections were cut using a rotative 
microtome, mounted on gelatin-coated slides and 
processed for immunohistochemistry. These sections 
were deparaffinised in xylene and dehydrated. They 
were immersed in citrate buffer (pH 6) and subjected 
to microwave irradiation twice for 5 min (750 W). 
Subsequently, all sections were treated for 30 min 
with 0.3% hydrogen peroxide in methanol to quench 
endogenous peroxidase activity. To block non-specific 
binding, the slides were incubated in 6% normal goat 
serum in PBS for 30 min at room temperature. The 
slides were incubated overnight at 4°C with primary 
mouse monoclonal antibodies (dilution: 1/100) aga-
inst human VEGF (Santa Cruz, sc-53462), against 
human TNFa (Santa Cruz, sc-52746) and with primary 
rabbit polyclonal antibody against human IL-1b (Santa 
Cruz, sc-7884), against human PEDF (Santa Cruz, 
sc-25594) and against human TGFb1 (Santa Cruz, sc-
146). Optimal antisera dilutions and incubation times 
were assessed in a series of preliminary experiments. 
After exposure to the primary antibodies, slides were 
rinsed twice in phosphate buffer and incubated for 
1 h at room temperature with the appropriate secon-
dary biotinylated goat anti-mouse or anti-rabbit IgG 
(vector laboratories Burlingame, CA, USA, BA9200 
and BA1000) and with peroxidase-conjugated avidin 
(Vector laboratories, Burlingame, CA, USA, Vecta-
stain Elite ABC Kit Standard* PK 6-100) for 30 min. 
After a further wash with phosphate buffer, slides 
were treated with 0.05% 3,3-diaminobenzidine and 
0.1% H2O2. Finally, sections were counterstained with 
Mayer’s haematoxylin and observed using a light mic- 
roscope. Negative control experiments were done: 
(i) by omitting the primary antibody; (ii) by substitu-
ting the primary antibody with an equivalent amount 
of non-specific immunoglobulins; (iii) by pre-incuba-
ting the primary antibody with the specific blocking 
peptide (antigen/antibody = 5 according to supplier’s 
instructions). The staining assessment was made by 
2 experienced observers in light microscopy. We as-
sessed the immunoreactivity for VEGF, PEDF, TGFb1; 
IL-1b, TNFa in the retina. The intensity of the immune 
reaction was assessed microdensitometrically using 
an IAS 2000 image analyser (Delta Sistemi, Rome, 
Italy) connected via a TV camera to the microscope. 
The system was calibrated taking the background 
obtained in sections exposed to non-immune serum 
as zero. Ten 100 mm2 areas were delineated in each 
section by a measuring the diaphragm. 
ResUlTs 
Electron microscopy 
Transmission electron microscopy (TEM) examina-
tion of the retinas taken from patients with chronic 
ocular inflammation showed the lumen of retinal 
capillaries to be completely occluded by glial cells 
and increased thickening of the capillary basement 
membrane (BM) with some electro-dense granules, 
compared with those of the control patients. TEM 
examination of the cross sections of normal human 
retinal capillaries (age 71–80 years old) showed well 
preserved endothelial cells with apparently normal 
mitochondria, endoplasmic reticulum, Golgi appa-
ratus and several pinocytotic vesicles adjacent to the 
plasma membrane. The external layer of the capillary 
BM was significantly thickened, containing only a few 
processes of pericytes but several electro-translucent 
vacuoles. The retinal capillaries were surrounded by 
numerous glial cells (Fig. 1). The BM consisted of: an 
inner subendothelial BM interposed between endo-
Figure 1. Transmission electron microscopy of a normal aged 
retinal capillary (cap). Well preserved endothelial cells (ec) show 
normal appearance mitochondria, endoplasmic reticulum, Golgi 
apparatus and several pinocytotic vesicles adjacent to the plasma 
membrane. External layer of capillary basement membrane (bm) 
is significantly thickened and contains only a few processes of peri-
cytes (pc) but several electro-translucent vacuoles. The capillary  
is surrounded by numerous glial cells (gc); 71-year-old man;  
magnification: 20,000×.
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thelial cells and pericytes, and an external BM placed 
between the pericytes and Müller glial cells. TEM 
examination of retinas removed from post-traumatic 
chronic ocular inflammation or post-thrombotic va-
scular glaucoma patients showed increased thicke-
ning of the capillary BM compared with those of the 
controls. The lumen of the capillaries was occluded by 
several processes of glial cells, containing numerous 
microtubules and a few organelles. Endothelial cells 
and pericytes were absent (Figs. 2, 3). The capillary 
walls were formed mainly by a slightly thickened BM, 
containing a few cytoplasmic processes of pericytes 
but some electro-dense granules and vacuoles 
(Figs. 4, 5). These data indicate that chronic ocular 
inflammation, caused by trauma or thrombotic vascu-
lar glaucoma, is followed by an immediate increase 
in capillary permeability accompanied by retinal oe-
dema. This functional capillary change is followed 
by structural damage to the capillary wall. Thrombus 
formation occurred in the damaged vessels, thus pro-
ducing areas of stasis and associated retinal haemor- 
rhages. Finally, there is a complete loss of the capillary 
endothelium and pericytes, and acellular capillaries 
are invaded by proliferating glial cell processes, thus 
producing permanent capillary closure. These pro-
cesses of glial cells, surrounded by some remnants 
of plasma or erythrocytes, occasionally fill the whole 
capillary lumen. The processes of Müller cells enter 
the capillary lumen through small gaps in the BM, 
and often the spaces formerly occupied by pericytes 
Figure 2. Post-traumatic chronic inflammation of the retina. An 
occluded retinal capillary can be seen in the central area of this pic-
ture. The retina contains mainly glial cells (gl), and a microglia (mg) 
can also be seen; 38-year-old man; magnification: 14,000×.
Figure 3. Higher magnification of the previous picture. Capillary 
lumen is occluded by several processes of glial cells (gl), which 
contains numerous microtubule and a very few organelles. Endo-
thelial cells are absent. Capillary wall is formed mainly by slightly 
thickened basement membrane (bm), which contains a few cyto-
plasmic processes of pericytes but some electro-dense granules, 
probably lipids. In several places capillary basement membrane 
forms extensions into the intercellular places (ext); 38-year-old 
man; magnification: 34,000×.
Figure 4. Another occluded retinal capillary of the same eye. Ca-
pillary lumen is completely occluded by glial cell (gl), endothelial 
cells and pericytes are absent, capillary basement membrane (bm) 
is slightly thickened and contains some electro-dense granules, 
the surrounding retina is replaced by glial cells; 38-year-old man; 
magnification: 30,000×.
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were often also filled by glial cells. The glial cells inside 
the capillaries usually contain smooth endoplasmic 
reticulum, some ribosomes, microfilaments, small 
mitochondria, vesicles of lipid and, occasionally, the 
cells have the appearance of macrophages.
Immunohistochemical analysis
Under light microscope, fragments of retina from 
post-traumatic chronic ocular inflammation or post-
-thrombotic vascular glaucoma patients were exami-
ned. Sections of retina of chronic ocular inflammation 
patients exposed to the primary/secondary antibo-
dies developed a dark-brown (intense), yellow-brown 
(slight) or no appreciable immunostaining.
VEGF immunoreactivity was observed in cells in-
filtrating the subretinal space. Immunoreactivity for 
VEGF was observed in the detached retina and dilated 
vessels (Fig. 6). There were no significant correlations 
between VEGF immunoreactivity in retinal endothelial 
cells and the presence of retinal vascular abnorma-
lities. In contrast, normal retinae did not contain 
macrophage infiltration or vascular abnormalities. 
VEGF immunoreactivity was not observed in the blood 
vessels situated in the normal retina (data not shown). 
Cytoplasmic immunoreactivity for VEGF was weakly 
noted in the inner nuclear layer. An intense reaction 
for PEDF was seen in the inner/outer segments in the 
acellular zone containing rods and cones (Fig. 7). The 
reaction was primarily positive in the retinal pigment 
epithelial layer, but was rarely positive in the cyto-
plasm of other retinal cells. PEDF positive cells were 
detected to some degree in all specimens (pathologic 
and control), PEDF showed a weak immunoreactivity 
in the new vessels where fibrosis was prominent but 
strong immunoreactivity for PEDF was detected in 
Figure 5. Occluded retinal capillary in post-thrombotic vascular glauco-
ma. Capillary lumen is occluded by glial cells (gl), basement membrane 
(bm) significantly thickened and contains numerous vacuoles and 
electro-dense granules; 81-year-old women; magnification 25,000×.
Figure 6. Immunohistochemical analysis of human retina for 
vascular endothelial growth factor (VEGF). VEGF stain of human 
retina section shows a cytoplasmic localisation in the inner nuclear 
layer. VEGF immunoreactivity was expressed in cells infiltrating the 
subretinal space and in the blood vessels (40×). 
Figure 7. Immunohistochemical analysis of human retina for pig-
ment epithelium-derived factor (PEDF). PEDF immunoreactivity 
was positive in the retinal pigment epithelial layer, but was rarely 
positive in the cytoplasm of other retinal cells (40×).
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the retinal pigment epithelium cells. Strong immu-
nostaining for IL-1b was observed in the ganglion cell 
layer, the inner nuclear layer and in the retinal pig-
ment epithelium (Fig. 8). IL-1b can induce retinal pe-
rivascular macrophage activation Furthermore, IL-1b 
appears to be involved in the disruption of BRB in 
diabetic retinopathy. Staining for TNFa was observed 
on the retinal vascular endothelium, on infiltrating 
cells and on the extracellular matrix of 9 samples, 
furthermore is widely distributed within fibrovascular 
membranes (Fig. 9). Immunohistochemical labelling 
for TGFb1 is associated with endothelial, mural and 
microglial cells (Fig. 10). Our findings reveal the exi-
stence of a consecutive TGFb1 signalling in human 
retina required for the survival of both vascular and 
neural cells. These findings are consistent with the 
expression of TGFb1 by pericytes and endothelial 
cells of the human retinal microvasculature. Further, 
these observations support our hypothesis that the 
relatively high ratio of pericytes to endothelial cells 
in the retina, compared to other vessel beds, should 
lead to significant activation of latent TGFb1.
DIsCUssION
Electron microscopic observation visualised the 
morphological changes in the retinal capillaries detec-
ted during chronical ocular inflammation. Assessment 
of electron microscopy confirmed the occluded state 
of the retinal capillaries by glial cells in patients suf-
fering from post-traumatic chronic ocular inflamma-
tion or post-thrombotic vascular glaucoma. Recent 
studies have identified several possible cellular chan-
ges which may contribute to the pathogenesis of va-
scular leakage in inflammation [45]. Vascular damage 
in the retinal specimens was accompanied by intracel-
lular retinal oedema [6]. The earliest morphological 
change detected in the capillaries was flattening of 
some of vessels and the formation of a slit-like lumen. 
The flattened capillaries were usually found in the 
deeper layers of the retina and occasionally appeared 
to be were compressed by the surrounding oedema 
[4]. The flattened appearance of the retinal capilla-
ries was accompanied by more specific degeneration 
Figure 8. Strong immunostaining for interleukin-1beta (IL-1b) was 
observed in the ganglion cell layer, the inner nuclear layer and in 
the retinal pigment epithelium (40×).
Figure 9. Immunohistochemical analysis of human retina for tumo-
ur-necrosis factor alpha (TNFa). Staining for TNFa was observed 
on the retinal vascular endothelium, on infiltrating cells and on the 
extracellular matrix (40×).
Figure 10. Immunohistochemical analysis of human retina for 
transforming growth factor beta (TGFb1). TGFb1 immunoreactivity 
was expressed in endothelial cells of the human retinal microva-
sculature, mural and microglial cells (40×). 
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of the endothelium and pericytes. These capillaries 
showed an increased number of vacuoles appeared 
in the cells, thin and electrodense endothelium and 
endothelial gaps. Necrosis of the capillary endothe-
lium and the resulting exposure of the BM resulted 
in the formation of platelet thrombi. Thus, capillary 
degeneration leads to the formation of areas of com-
plete stasis in the microvasculature. After the first 
appearance of thrombi in the capillaries there was 
clearly stasis in the small vessels and many capillaries 
were filled with packed erythrocytes. Degeneration of 
the endothelium and pericytes appeared to proceed 
rapidly in the anoxic conditions associated with stasis 
[3, 18]. The closed state of retinal capillaries probably 
became irreversible once of proliferating glial cells 
processes head entered the ghost vessels. Gaps in 
the BM which allowed entry of glial cells were seen 
infrequently, and the BM appeared to be resistant 
to degenerative changes. Probably, the Müller cell 
processes entered the vessels through the same gaps 
which had permitted the earlier haemorrhages [28]. 
Our observations confirmed functional and later stru-
ctural changes in the retinal capillaries during chronic 
ocular inflammation. Retinal capillaries showed incre-
ased thickening of the BM, which contained a few 
cytoplasmic processes of pericytes and electrodense 
granules. We also detected irreversible occlusion of 
retinal capillaries by proliferating Müller cells and 
the absence of endothelial cells and pericytes. These 
vascular changes and capillary closure in the retinal 
microvasculature probably became permanent as 
a result of significant thickening of the BM. 
Müller cells constitute an anatomic and functional 
link between neurons and vessels [41]. These glial 
cells play a central role in retinal glucose metabolism 
[53], regulation of retinal blood flow [41] and ma-
intenance of the BRB [51]. Therefore, these factors 
make Müller cells a target and potential key player in 
the vascular alterations of the retina, such as vascular 
permeability. A previous study indicated that Müller 
cells assemble an acute-phase response, which is 
associated with retinal up-regulation of the pro-
-inflammatory cytokine IL-1b [26]. IL-1b induces the 
recruitment of mononuclear and polymorphonuc-
lear leukocytes that enter the retina predominantly 
through the retinal vasculature and that appear to 
migrate through retinal endothelial cells. These re-
sults suggest that IL-1b may be an important factor in 
the pathogenesis of human retinal inflammation [9]. 
Leukocyte recruitment to the retina caused by IL-1b 
is essential for inducing breakdown of the BRB, but 
differs from TNFa, which induces disruption of the 
BRB [9]. Il-1b could play a pathogenic role in the 
development of chronic ocular inflammation, incre-
asing levels of ICAM-1 and endothelin [21], leukocyte 
adhesion and breakdown of the blood-tissue barrier 
[8, 21], neuronal death [44], and activation of mic-
ro- and macroglial cells [27]. Paracrine interactions 
between Müller and endothelial cells seem to play 
an important role in modulating several functions, 
such as intracellular retinal transport and protection 
against oxidative stress in retinal capillary endothelial 
cells. Abukawa et al. [1] demonstrated the possibility 
that Müller cells may modulate retinal angiogenesis 
by altering their secretion of TGFb1. During the early 
stage of a chronic ocular inflammatory disorder, pro-
-inflammatory proteins, such as ICAM-1 and TNFa, 
are up-regulated, and increased leukostasis is ob-
served [30, 38, 46]. These early pathologic changes 
are associated with up-regulation of VEGF [31, 35, 
37]. Müller cell derived-VEGF plays a causative role in 
retinal neovascularisation, vascular leakage, vascular 
lesions and inflammation [55]. Differently, PEDF is 
a major endogenous angiogenic inhibitor in the eye 
[13], and its role in neovascular diseases has been 
studied extensively [20, 24, 25]. PEDF was shown to 
reduce VEGF-induced vascular leakage, implying its 
involvement in the regulation of vascular permeabi-
lity [34]. The retinal levels of inflammatory factors, 
including TNFa and MCP-1 were significantly lower 
in PEDF-injected eyes than that in the control eyes. In 
retinal Müller cells, specific down-regulation of PEDF 
resulted in a significant increase of TNFa production, 
indicating that PEDF is an endogenous inflammatory 
inhibitor able to reduce of vascular permeability. PEDF 
not only reduced VEGF levels in the retina but also 
decreased retinal VEGFR-2 levels, suggesting that 
the ability of PEDF to reduce the inflammation and 
permeability may be ascribed to the down-regulation 
of VEGF and its receptor [58].
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